News Conference News ESC 2021 No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER Michael O'Riordan September 02, 2021
News Conference News ESC 2021 Both Acute and Chronic Myocardial Injury in COVID-19 Impede 6-Month Survival Caitlin E. Cox September 01, 2021
News Conference News ESC 2021 Fixed-Dose Combo Therapy Slashes CVD Risk in Primary Prevention Michael O'Riordan August 31, 2021
News Conference News ESC 2021 PRONOUNCE: No Difference in CVD Risks With Degarelix and Leuprolide for Prostate Cancer Michael O'Riordan August 30, 2021
News Conference News ESC 2021 IAMI: Influenza Vaccine Beneficial for Post-MI Patients Michael O'Riordan August 30, 2021
News Conference News ESC 2021 Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD Michael O'Riordan August 29, 2021
News Conference News ESC 2021 Studies Reveal Surprising Benefits of Smoking Cessation and ‘Greenness’ L.A. McKeown August 28, 2021
News Daily News Marijuana Ups Bleeding, CVA Risks in PCI Patients: Registry Data Caitlin E. Cox August 16, 2021
News Daily News Largest Study of VITT After COVID-19 Vaccination Digs Into Lab, Clinical Features Todd Neale August 11, 2021
News Daily News Getting More Women in CV Research Will ‘Take a Village’ Yael L. Maxwell August 09, 2021
News Daily News Myocarditis, Pericarditis Rare After COVID-19 Vaccination: EMR Data Michael O'Riordan August 05, 2021
News Conference News HRS 2021 J-Curve for Alcohol and AF Risk? UK Biobank Offers ‘Glimmer of Hope’ Shelley Wood July 28, 2021
News Daily News Coffee Doesn’t Disturb Heart Rhythm: UK Biobank Analysis Caitlin E. Cox July 22, 2021